# Observational Carcinoma, Renal Cell studies: 61 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 61 trials that are observational for Carcinoma, Renal Cell that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Carcinoma, Renal Cell studies: 61 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/carcinoma-renal-cell

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 61
- Recruiting or not yet: 61
- Read on: November 19, 2026

## Trials

The 25 newest of 61, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07941830 | AI-Based Anatomy Recognition in Minimally Invasive Kidney Surgery | Chinese PLA General Hospital | Observational | Not yet recruiting | Kidney (Renal Cell) Cancer, Ureteropelvic Junction Obstruction, Upper Urinary Tract Carcinoma | 1,700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941830) |
| October 28, 2026 | NCT07901569 | Habitat Analysis of Tumor Thrombus for Vena Cava Wall Invasion in Renal Cell Carcinoma | Sponsor not shown (see the record) | Observational | Not yet recruiting | Carcinoma, Renal Cell, Inferior Vena Cava Tumor Thrombus | 273 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901569) |
| October 15, 2026 | NCT07874542 | Plasma DNA Methylation for Preoperative Classification of Renal Masses | RenJi Hospital | Observational | Recruiting | Renal Cell Carcinoma, Benign Renal Mass | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874542) |
| September 25, 2026 | NCT07841756 | Federated Learning in Renal Tumor Model | First Affiliated Hospital of Guangxi Medical University | Observational | Not yet recruiting | Renal Tumors | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07841756) |
| September 3, 2026 | NCT07803315 | Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy | University of Leipzig | Observational | Recruiting | Kidney Neoplasm, Renal Mass up to 7cm | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803315) |
| August 7, 2026 | NCT07753343 | Identification and Description of Patients With High-risk Non Metastatic RCC | University Hospital, Bordeaux | Observational | Recruiting | Renal Cell Carcinoma | 6,109 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753343) |
| August 4, 2026 | NCT07743749 | An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Observational | Recruiting | Renal Tumor, Kidney Neoplasm | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07743749) |
| June 18, 2026 | NCT07657325 | Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma | Tianjin Medical University Second Hospital | Observational | Recruiting | Renal Cell Carcinoma (RCC) | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07657325) |
| June 9, 2026 | NCT07636148 | Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance | Sponsor not shown (see the record) | Observational | Recruiting | Liver Cancer (Primary and Metastatic), Lung Cancer (Diagnosis), Bone Cancer Metastatic, Bone Cancer Tumor, Kidney... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636148) |
| March 20, 2026 | NCT07485114 | Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung... | Sponsor not shown (see the record) | Observational | Recruiting | Renal Cell Carcinoma (Kidney Cancer), Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Transitional Cell Carcinoma | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07485114) |
| March 12, 2026 | NCT07465458 | Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients | Humanitas Hospital, Italy | Observational | Not yet recruiting | Renal Carcinoma | 226 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07465458) |
| January 20, 2026 | NCT07351266 | Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Observational | Not yet recruiting | Renal Cell Carcinoma (Kidney Cancer) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07351266) |
| December 19, 2025 | NCT07294859 | Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy | Jinling Hospital, China | Observational | Recruiting | Nephrectomy, Renal Cell Cancer, AKI - Acute Kidney Injury | 285 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07294859) |
| November 24, 2025 | NCT07246759 | Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis | OncoHost Ltd. | Observational | Not yet recruiting | Non Small Cell Lung Cancer (NSCLC), Melanoma (Skin Cancer), Triple Negative Breast Cancer (TNBC), RCC, Renal Cell... | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07246759) |
| November 21, 2025 | NCT07243067 | Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer | Mayo Clinic | Observational | Not yet recruiting | Renal Cell Carcinoma, Clear-cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Chromophobe Renal Cell... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07243067) |
| November 21, 2025 | NCT07240610 | Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma | Sponsor not shown (see the record) | Observational | Recruiting | Renal Cell Cancer Metastatic | 145 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07240610) |
| November 18, 2025 | NCT07234656 | Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer | Sponsor not shown (see the record) | Observational | Recruiting | Fear of Cancer Recurrence, Renal Cell Carcinoma (Kidney Cancer) | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07234656) |
| September 10, 2025 | NCT07166445 | Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT | Peking University First Hospital | Observational | Recruiting | Carcinoma, Renal Cell, Diagnostic Imaging, Pathology, Deep Learning | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07166445) |
| August 15, 2025 | NCT07124000 | DESTINY-PANTUMOUR04 | AstraZeneca | Observational | Recruiting | Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer, Cervical Cancer, Endometrial Cancer, Esophageal Cancer, Gall Bladder... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07124000) |
| August 12, 2025 | NCT07118813 | Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Observational | Recruiting | Renal Cell Carcinoma (Kidney Cancer) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07118813) |
| August 12, 2025 | NCT07117227 | Validation of RCC Predicting Model With Emulated-target Trial | Peking University Third Hospital | Observational | Recruiting | Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Tumor Thrombus, Prognosis, Prognostic Cancer Model... | 4,700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07117227) |
| June 12, 2025 | NCT07018037 | Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma | Regina Elena Cancer Institute | Observational | Recruiting | Renal Cell Carcinoma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07018037) |
| May 7, 2025 | NCT06960798 | Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno) | University of Oklahoma | Observational | Recruiting | Prostate Cancer, Renal Cell Carcinoma (RCC) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06960798) |
| April 8, 2025 | NCT06916624 | Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma | The Affiliated Hospital of Qingdao University | Observational | Recruiting | Renal Cell Carcinoma (RCC), Clear Cell Renal Cell Carcinoma (ccRCC) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06916624) |
| March 28, 2025 | NCT06899789 | Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis | Fondazione IRCCS Policlinico San Matteo di Pavia | Observational | Recruiting | Immune Checkpoint Inhibitors-induced Colitis, Advanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney... | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06899789) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Jinling Hospital, China | 3 |
| Peking University Third Hospital | 2 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Mayo Clinic | 2 |
| Peking University First Hospital | 2 |
| National Cancer Institute (NCI) | 2 |
| IRCCS San Raffaele | 2 |
| Yonsei University | 2 |
| Spanish Oncology Genito-Urinary Group | 1 |
| RenJi Hospital | 1 |
| University of Texas Southwestern Medical Center | 1 |
| Assiut University | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| OncoHost Ltd. | 1 |
| Tianjin Medical University Second Hospital | 1 |
| [Power Life Sciences Inc.](https://specstream.ai/data/clinical-trials/company/power-life-sciences-inc) | 1 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
| University of Oklahoma | 1 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 1 |
| First Affiliated Hospital of Guangxi Medical University | 1 |
| St. Antonius Hospital | 1 |
| Hospital of Macerata | 1 |
| National Taiwan University Hospital | 1 |
| VastBiome | 1 |
| University Hospital, Bordeaux | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 19 |
| United States | 14 |
| Italy | 11 |
| Germany | 5 |
| Spain | 4 |
| France | 4 |
| Netherlands | 3 |
| South Korea | 2 |
| Israel | 1 |
| Taiwan | 1 |
| Denmark | 1 |
| Japan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Tax preparation firms in the United States](https://specstream.ai/data/businesses/tax-preparation-firms/united-states)
- [Handyman services in the United States](https://specstream.ai/data/businesses/handyman-services/united-states)
- [Woodworking supply stores in the United States](https://specstream.ai/data/businesses/woodworking-supply-stores/united-states)
- [Laser cutting companies in the United States](https://specstream.ai/data/businesses/laser-cutting-companies/united-states)
- [Backflow companies in the United States](https://specstream.ai/data/businesses/backflow-companies/united-states)
- [Orthopedic surgery practices in the United States](https://specstream.ai/data/businesses/orthopedic-surgery-practices/united-states)
